| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Former 10% Owner +1 more
17 companies
Baker Bros. Advisors LP is a Director, 10% Owner at ACAD with holdings across 17 companies. Recent SEC Form 4 filings include 121 buys and 6 sells.
Estimated insider holdings value: $7413.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | ONC Beone Medicines Ltd. | Director | Sell | 732,827 | $260.00 | $190,535,020.00 | -7.7% | -9.2% | +16.5% | |
| Dec 30, 2024 | KALA Kala Bio, Inc. | 10% Owner | Buy | 310,559 | $6.44 | $1,999,999.96 | +34.8% | -16.6% | -91.8% | |
| Dec 16, 2024 | BCYC Bicycle Therapeutics Plc | Director, 10% Owner | Buy | 2,039,119 | $14.16 | $28,882,383.24 | +4.2% | -34.0% | -51.7% | |
| Dec 9, 2024 | ONC Beone Medicines Ltd. | Director | Sell | 1,037,017 | $187.27 | $194,200,043.13 | -4.9% | +16.9% | +53.5% | |
| Aug 20, 2024 | KYMR Kymera Therapeutics, Inc. | Director | Buy | 1 | $46.41 | $46.41 | - | -8.8% | -8.9% | |
| Dec 14, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 101,792 | $221.20 | $22,516,576.85 | +0.4% | +17.1% | +30.7% | |
| Dec 12, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 28,267 | $217.49 | $6,147,730.21 | +0.1% | +17.1% | +38.0% | |
| Nov 21, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 64,350 | $188.47 | $12,128,340.27 | +0.4% | +21.9% | +68.3% | |
| Nov 20, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 58,714 | $178.51 | $10,481,110.25 | +0.2% | +20.9% | +65.3% | |
| Nov 15, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 49,387 | $158.13 | $7,809,558.62 | +1.5% | +26.7% | +87.2% |